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Abstract—Interferon-alpha (IFN-a) is an important mediator of antiviral immune responses. It is also used clini-
cally in the treatment of hepatitis-C infection. Though eﬀective, IFN-a-based therapies can often impair mood,
motivation and cognition, which when severe can appear indistinguishable from major depression. In susceptible
patients, fatigue and motivational impairment emerge early and have been linked to changes in basal ganglia (stri-
atal) metabolism, neurochemistry and microstructural integrity. Here we use neurite orientation dispersion and
density imaging (NODDI) modeling of multi-shell diﬀusion MRI to investigate whether changes in orientation-
dispersion index (ODI) or neurite density index (NDI) can predict the later emergence of IFN-a-induced fatigue.
Eighteen patients initiating IFN-a-based treatment for hepatitis-C underwent diﬀusion MRI and blood sampling
at baseline and 4 h after their ﬁrst IFN-a injection. They were then followed up with regular psychological assess-
ments for 12 weeks of treatment. IFN-a injection stimulated an acute inﬂammatory cytokine response and evoked
acute fatigue that peaked between 4 and 12 weeks of treatment. Within the brain, IFN-a induced an acute increase
in NDI in patients that experienced a simultaneous increase in IFN-a-induced fatigue but not in patients that did
not. Acute changes in striatal microstructure additionally predicted the continued development of fatigue but not
mood symptoms 4 and 8 weeks later into treatment. Our ﬁndings highlight the value of NODDI as a potential
in vivo biomarker of the central eﬀects of peripheral inﬂammation. We highlight the exquisite sensitivity of the
striatum to IFN-a and further implicate striatal perturbation in IFN-a-induced fatigue.
This article is part of a Special Issue entitled: MRI and Neuroinflammation.  2018 The Authors. Published by Elsevier Ltd on
behalf of IBRO. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Interferon-alpha (IFN-a) is a type I interferon that is
released by specialized immune cells (Liu, 2005) and
virally infected cells and promotes broad antiviral immune
responses. These anti-viral properties of IFN-a are har-
nessed clinically in the treatment of Hepatitis-C infection.
However, despite its good clinical eﬃcacy, direct and/or
indirect actions of IFN-a on the brain frequently result inhttps://doi.org/10.1016/j.neuroscience.2017.12.040
0306-4522/ 2018 The Authors. Published by Elsevier Ltd on behalf of IBRO.
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motivation, mood, and cognitive impairments (Capuron
et al., 2002). When severe, these changes can appear
indistinguishable from major depression and provide pow-
erful support for inﬂammatory theories of depression
(Musselman et al., 2001; Bonaccorso et al., 2001;
Dantzer et al., 2008). Symptoms such as fatigue, psy-
chomotor slowing and motivation change typically emerge
rapidly, often within hours of the ﬁrst IFN-a injection sug-
gesting that IFN-a can rapidly engage immune–brain
communicatory pathways (Capuron et al., 2002; Dowell
et al., 2016).
Unlike inﬂammation induced using bacterial antigens
(Rosenkranz et al., 2005; Harrison et al., 2009, 2015;
Lekander et al., 2016), the imaging literature provides lim-
ited evidence that the central eﬀects of IFN-a result from
engagement of visceral aﬀerents and interoceptive path-
ways to insula (Capuron et al., 2007, 2012; Haroon/licenses/by/4.0/).
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to exert its eﬀects predominantly through direct actions
on the brain. The blood–brain interface (BBI) is permeable
to IFN-a with greater permeability observed in sub-cortical
than cortical regions (Pan et al., 1997; Banks, 2016). In
rodents, peripheral IFN-a also leads to rapid up-
regulation of interferon-sensitive genes with subcortical
areas (Wang and Campbell, 2005; Wang et al., 2008).
This sensitivity of sub-cortical and particularly striatal
structures to INF-a is also observed in human clinical
and imaging studies (Lebon et al., 1988). For example,
chronic IFN-a administration is associated with bilateral
(though left predominant) increases in striatal 18ﬂuoro-
deoxy-glucose (18FDG) uptake (Capuron et al., 2012),
left-, but not right-sided, increases in striatal glutamate/
creatine ratio (Haroon et al., 2014); and increased striatal
18ﬂuorodopa uptake (Capuron et al., 2012). Recently, we
have also demonstrated that IFN-a results in rapid (within
4 h) changes in bilateral (though left predominant) striatal
magnetization transfer (MT), speciﬁcally an increase in
MT from free (water) to molecular-bound protons (kf)
and a complementary reduction in free water spin–spin
relaxation time (T2f) (Dowell et al., 2016). Across each
of these studies striatal changes correlate with between-
subject sensitivity to IFN-a-induced motivational change
and/or subjective fatigue.
The molecular substrate underlying this IFN-a-
associated change in MT is currently uncertain. In
white matter, myelin dominates the MT exchange
process (Kucharczyk et al., 1994; Odrobina et al.,
2005), though in other neuronal structures processes
such as inﬂammation (Stanisz et al., 2004), metabolic
(Giulietti et al., 2012) and pH changes (Kucharczyk
et al., 1994; Gillies et al., 2004; Louie et al., 2009)
appear to play an important role. Previous data have
linked regional changes in kf to altered ﬂuorodeoxyglu-
cose (FDG) uptake (Giulietti et al., 2012; Harrison
et al., 2015) suggesting a likely metabolic mediator. In
brain, astrocytes account for approximately 50% of all
glucose consumption (Be´langer et al., 2011; Chuquet
et al., 2010). This increases further during glutaminergic
activity (Porras et al., 2004) as is observed following
IFN-a therapy (Haroon et al., 2014). Consequently, there
is a sustained increase in lactate release from glia (Lin
et al., 2010), a metabolite which contains both hydroxyl
and carboxyl groups that are known to heavily inﬂuence
MT exchange processes (Ceckler et al., 1992).
Changes in kf are accompanied by co-localized
changes in striatal T2f (Harrison et al., 2015; Dowell
et al., 2016). Although these MT metrics are sensitive
markers for subtle microstructural change, they are not
speciﬁc and are diﬃcult to attribute to particular biologi-
cal processes. Further characterization is possible with
the aid of diﬀusion-weighted magnetic resonance imag-
ing (MRI). In particular, we use neurite orientation dis-
persion and density imaging (NODDI) (Zhang et al.,
2012) to model the diﬀusion-weighted signal within three
distinct diﬀusion environments: unrestricted (isotropic dif-
fusion) that broadly correspond to diﬀusion in the CSF,
hindered (Gaussian displacement pattern) to extra-
cellular, and restricted (non-Gaussian displacement pat-Please cite this article in press as: Dowell NG et al. Interferon-alpha-Induced Changes in NODDI Predispose totern) to intracellular spaces. The NODDI model uses an
orientation-dispersed cylindrical model where intracellu-
lar spaces are assumed to be cylinders of zero radius
(restricted diﬀusion), while the extracellular spaces are
characterized by hindered diﬀusion and modeled by a
cylindrically symmetric diﬀusion tensor. The signal attrib-
uted to the intracellular spaces is assumed to be indica-
tive of the neurite density. This neurite density index
(NDI) ranges from 0 to 1 (NDI is typically lower in gray
than white matter). A Watson distribution is then used
to model the orientation distribution of the cylinders,
which is quantiﬁed using the orientation dispersion index
(ODI). Highly parallel white matter structures e.g. corpus
callosum have ODI values close to 0 and areas like gray
matter rich in multi-directional dendritic structure have
values closer to 1.
We acquired multi-shell diﬀusion MRI in a group of 18
patients beginning IFN-a treatment for Hepatitis-C.
Diﬀusion MRI was acquired at baseline (Mean 7 days
prior to initiating therapy) and again 4 h after their ﬁrst
dose of IFN-a. Clinical assessments were completed at
both scanning sessions and then again at 4, 8, and 12
weeks of treatment to quantify and characterize
symptoms of fatigue and depression and relate these to
acute changes in diﬀusion MRI. The striatum is known
to be sensitive to chronic IFN-a (Harrison, 2017). Our pri-
mary aim was to determine whether striatal regions that
demonstrate shifts in MT also show alterations in diﬀu-
sion, speciﬁcally with NDI, which is sensitive to intracellu-
lar water diﬀusion and likely to be aﬀected by changes in
neuronal or possibly astrocytic processes and the ODI of
these processes. We analyzed this in two ways: as a main
eﬀect of IFN-a and as a correlation with IFN-a-induced
fatigue. We additionally investigated whether acute
changes in NODDI metrics are also predictive about the
later development of IFN-a-induced fatigue or mood
change.EXPERIMENTAL PROCEDURES
Participants
Eighteen individuals (mean age = 47 years, SD = 11 ye
ars, 13 male) with a diagnosis of hepatitis-C were
recruited. All were ﬂuent in English, aged between 18
and 64 years and fulﬁlled NICE guidelines for receiving
pegylated IFN-a-based therapy. All participants had a
baseline psychiatric evaluation of current mental state
and previous psychiatric history, using the Mini
Neuropsychiatric Inventory (MINI). Participants were
excluded if they were receiving treatment for depression
at study enrollment, had a history of psychotic illness,
were not abstinent from substance misuse for at least 6
months, had HIV co-infection or any cause for liver
disease other than hepatitis-C virus. The study was
approved by the Cambridge Central National Research
Ethics Committee. All subjects provided written informed
consent. Seven participants recruited to this study also
contributed to the qMT data reported in Dowell et al.
(2016).the Development of Fatigue. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2017.12.040
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The study utilized a prospective cohort design.
Participants were evaluated at baseline (mean 7 days
before treatment), 4 h after their ﬁrst IFN-a injection and
at weeks 4, 8, and 12 of IFN-a-based therapy. Fatigue
and depressive symptoms were evaluated at each visit
using a visual analog scale (fVAS) where participants
marked their degree of fatigue on a 10-cm scale and the
Hamilton Depression Rating Scale (HAMD) respectively.
MRI followed by blood sampling, was repeated at
baseline and 4 h after the ﬁrst IFN-a injection.
Behavioral analyses
Eﬀects of IFN-a on fatigue and depression were analyzed
in SPSS 23.0 (IBM Corp., Armonk, New York, USA) using
repeated-measures analyses of variance and subsequent
paired sample t tests or regression analyses,
respectively. Mauchly’s sphericity test was performed,
and results reported followed the Greenhouse–Geisser
correction of degrees of freedom where appropriate.
Cytokine analyses
Blood (20 mL) was drawn into Vacutainer tubes (Becton
and Dickinson, Franklin Lakes, New Jersey, USA)
containing ethylenediaminetetraacetic acid anticoagulant
then centrifuged at 1250g for 10 min. Plasma was
removed, aliquoted, and frozen at 80 C before
analysis. Plasma IFN-a was measured using high-
sensitivity VeriKine ELISA (Human IFN Alpha Multi-
Subtype ELISA Kit (TCM); PBL Assay Science,
Piscataway, New Jersey). Interleukin-6 minimum
detectable dose (MDD) = 0.039 pg/mL, tumor necrosis
factor (TNF) MDD= 0.106 pg/mL, interleukin-1b MDD
= 0.057 pg/mL, and interleukin-10 MDD= 0.09 pg/mL
for the high-sensitivity Quantikine ELISAs (R&D
Systems, Abingdon, United Kingdom) and interleukin-1
receptor antagonist MDD= 6.3 pg/mL for the
Quantikine ELISA.
MR imaging
MR imaging was performed on a Siemens Avanto
(Siemens, Erlangen, Germany), equipped with a 1.5-T
magnet and 32-channel phased-array receive-only head
coil. Multi-shell diﬀusion-weighted data were acquired
with single-shot, twice-refocused pulse gradient spin-
echo echo planar imaging (voxel size 2.5  2.5  2.5 m
m3, 60 axial slices, matrix size 96  96, ﬁeld of view 24
0  240 mm2, repetition time = 8400 ms, echo time = 9
9 ms). Three b-value shells were acquired with b= 300,
800 and 2400 s/mm2 with 8, 30 and 60 non-colinear
diﬀusion-weighted directions, respectively. Eleven
images with no diﬀusion weighting (b  0) were
acquired. Total acquisition time was 17 min.
Image analysis
Diﬀusion data were ﬁrst movement-corrected and eddy-
current-corrected using the eddy_correct tool provided
in FSL (FMRIB Software Library version 5.0.7, Oxford,Please cite this article in press as: Dowell NG et al. Interferon-alpha-Induced Changes in NODDI Predispose to thUK). The MCFLIRT tool was used to quantify subject
movement across the cohort during each imaging
session. The NODDI model was ﬁtted to the data using
the NODDI toolbox (http://mig.cs.ucl.ac.uk/mig/mig/
index.php/?n=Tutorial.NODDImatlab/) for Matlab (The
MathWorks, Inc., Natick, MA, USA). Analysis took
approximately 2 h per participant on a high-performance
computing cluster with 128 compute cores (AMD
86_64, 2.4 GHz) to yield whole-brain maps of NDI,
isotropic water diﬀusion fraction (Viso) and ODI.
Symmetric diﬀeomorphic image registration from
Advanced Normalization Tools (ANTs, version 2.x;
http://stnava.github.io/ANTs) was then used to deform
non-diﬀusion-weighted (b0) images to a common MNI
image space. These deformation matrices were then
used to transform the whole-brain NODDI parameter
maps to MNI space to permit group-level statistical
comparison. Parameter maps were then smoothed with
an 8-mm3 full width at half maximum Gaussian kernel.
Normalized parameter maps were then statistically
analyzed using Statistical Parametric Mapping (SPM
version 12, Wellcome Trust Centre for Neuroimaging,
University College London, United Kingdom; http://
www.ﬁl.ion.ucl.ac.uk/spm/). Speciﬁcally, voxel-wise
paired-sample t-tests were used to identify acute eﬀects
of IFN-a on regional NDI and ODI parameters and
voxel-wide regression analyses to investigate the link
between these MR-derived microstructural indices and
fatigue.
Regions of interest (ROI)
We deﬁned four a priori ROIs for analyzing the eﬀects of
IFN-a: left and right striatum and left and right insula,
matching those used in our previous studies (Harrison
et al., 2015; Dowell et al., 2016). Masks were produced
using the WFU Pickatlas (http://fmri.wfubmc.edu/soft-
ware/pickatlas) then eroded where necessary, to avoid
partial volume eﬀects from cerebrospinal ﬂuid (CSF).
Mean NDI and ODI were calculated for each ROI then
paired t-tests conducted using SPSS. Acute changes in
fatigue and mood were correlated with mean NDI and
ODI within each ROI using SPSS.
Multiple comparisons
Whole-brain-corrected cluster signiﬁcance was
determined using Family-Wise Error (FWE) correction.
Only clusters surviving a FWE correction a< 0.05 after
thresholding at an uncorrected statistical threshold of p
< 0.001 are reported for whole-brain analyses. Clusters
surviving a FWE small-volume correction a< 0.05 after
thresholding at an uncorrected statistical threshold of p
< 0.001 are reported for each ROI.
RESULTS
Inﬂammatory cytokine response to IFN-a
Initial IFN-a injection was associated with 31-fold
increase in plasma IFN-a (from mean ± SE) (1.94 ± 1.
31 pg/mL at baseline to 61.01 ± 13.73 pg/mL at 4 h, t5
= 4.24, p< 0.01). We also observed a fourfolde Development of Fatigue. Neuroscience (2018), https://doi.org/10.1016/j.neuroscience.2017.12.040
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25 pg/mL, t12 = 3.75, p= 0.003). Plasma TNF and
interleukin-1b were not signiﬁcantly altered at this time
point (3.11 ± 0.68 pg/mL to 2.86 ± 0.58 pg/mL, t12 =
0.330, p= 0.747, and 0.0.335 ± 0.080 pg/mL to 0.333
± 0.077 pg/mL, t5 = 0.021, p= 0.984), though there
was a moderate increase in interleukin-1 receptor
antagonist from 196.97 ± 40.13 pg/mL to 549.79 ± 172
.45 pg/mL (t12 = 2.23, p= 0.045) and interleukin 10
from 0.782 ± 0.119 pg/mL to 1.76 ± 0.43 pg/mL (t12 =
2.52, p= 0.027) demonstrating a broader pro- and
anti-inﬂammatory cytokine response to IFN-a.Psychological eﬀects of IFN-a-based treatment
As we have previously reported, IFN-a treatment showed
a strong eﬀect on global fatigue (fVAS, F1,17 = 12.50, p
= 0.003) increasing from 40.89 ± 6.36 to peak 64.28
± 5.88 at 8 weeks. This increase in fatigue was rapid,
with a moderate eﬀect (g2 = 0.64) already observed at
4 h (t17 = 2.83, p= 0.015) demonstrating acute
sensitivity to peripheral IFN-a. As previously reported,
IFN-a-based therapy had a large eﬀect on HAMD
depression symptoms (t17 = 5.89, p< 0.001) with
signiﬁcant eﬀects observed from 4 weeks until the end
of treatment.MRI quality
No signiﬁcant diﬀerence in subject movement was
observed with imaging session (average root mean
square displacement was 1.46 mm (at baseline) and
1.30 mm (at 4 h); p= 0.278) and no participants
reported falling asleep during the scanning session.
Signal-to-noise ratio (SNR) of the raw diﬀusion-weighted
images was suﬃcient for the NODDI model (SNR >42
and >11 for b  0 and b= 2400 s/mm2 respectively).Acute eﬀects of IFN-a on NODDI metrics
Unlike our previous ﬁnding using MT imaging, we
identiﬁed no signiﬁcant main eﬀect of IFN-a within either
our left or right striatal ROI or within our left or right
insula ROI for either of the NODDI metrics (Table 1).
Similarly, there was no signiﬁcant eﬀect of IFN-a at the
whole-brain level.Table 1. Paired t-test results for changes in NDI and ODI (from baseline to 4 h
NODDI Metric ROI Baseline 4 h
NDI L striatum 0.4892 0.483
R striatum 0.4908 0.489
L insula 0.4538 0.454
R insula 0.4620 0.456
ODI L striatum 0.3902 0.393
R striatum 0.3893 0.386
L insula 0.4709 0.465
R insula 0.4795 0.474
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To investigate this further, we next investigated whether
this absence of an eﬀect at the group level was driven
by between-subject heterogeneity. Speciﬁcally, whether
eﬀects of IFN-a on striatal NODDI metrics emerged only
in participants that developed signiﬁcant IFN-a-induced
fatigue. This analysis demonstrated a signiﬁcant positive
correlation between acute changes in NDI and fatigue in
our (left) striatal and, to a lesser extent our (left) insula
ROI (Fig. 1; Table 2). Furthermore, the eﬀect size of
this association was modestly large (R2 = 0.52 and R2
= 0.46 respectively). When accounting for the change
in mood by regressing out change in HAMD score the
relationship between NDI and fatigue was preserved (R
= 0.682; p= 0.002 (acute), R= 0.607; p= p= 0.008
(at 4 weeks) and R= 0.673; p= 0.002 (at 8 weeks)).
This indicates that changes in fatigue and HAMD score
were largely independent. Similar to our MT ﬁndings,
acute changes in NDI within the left striatum but not the
insula additionally predicted the magnitude of fatigue
experienced 4 and 8 weeks later. There was no
signiﬁcant correlation between acute fatigue and fatigue
at 4 weeks (p= 0.055) and 8 weeks (p= 0.111).
In contrast, ODI did not signiﬁcantly correlate with
fatigue at any time-point. Similar to our prior MT
analysis, there was no signiﬁcant association between
changes in striatal (or insular) NDI or ODI and change
in mood score measured with HAMD. Whole-brain
analysis conﬁrmed the signiﬁcant positive correlation
between left striatum increases in NDI and development
of fatigue at 4 h post injection (Fig. 2). It also identiﬁed a
number of additional clusters elsewhere showing a
similar positive correlation with fatigue (Table 3). Of
note, no region showed a negative correlation between
changes in NDI and fatigue and no signiﬁcant
correlation was observed between change in ODI and
fatigue.DISCUSSION
IFN-a treatment of hepatitis C is characterized by a rapid
induction of fatigue that starts within hours of the ﬁrst
injection then typically increases throughout treatment
(Dowell et al., 2016). This motivationally impairing eﬀect
of IFN-a has been localized to changes in striatal function
across a broad range of imaging modalities. For example,
chronic IFN-a administration is associated with increases
in striatal 18FDG uptake (Capuron et al., 2007), anpost ﬁrst IFN-a injection) in the striatum and insula regions of interest
Mean diﬀerence t(1,17) p
4 0.00583 1.191 0.250
0 0.00180 3.99 0.695
3 0.000572 0.143 0.888
0 0.00606 1.697 0.108
1 0.00290 1.721 0.105
7 0.00259 1.279 0.218
4 0.00551 1.828 0.088
1 0.00533 1.946 0.068












Fig. 1. Plot of the correlation between acute change in NDI and acute
change in fatigue in the left striatum (R= 0.69, p= 0.001).
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and increased 18ﬂuorodopa uptake (Capuron et al., 2012).
Recently, we have also demonstrated that IFN-a acutely
impairs striatal MT, speciﬁcally a signiﬁcant increase in
forward magnetization transfer rate (kf) and a simultane-
ous decrease in the transverse relaxation time of the free
water component (T2f). In this study these MT metrics
were also predictive of the development of fatigue 4
weeks later into treatment. More constrained changes
were also detected in the insula, though these did not cor-
relate with fatigue.
Here we used NODDI in an overlapping cohort of
patients to provide a more complete and deeper
understanding of the subtle changes in brain
microstructure induced by IFN-a. Of particular interest
was the ability of NODDI to identify changes to the
intracellular water spaces within tissue. While NDI does
not provide a one-to-one mapping of neurite volume
fraction, it is sensitive to changes within the intracellular
component (Grussu et al., 2017). Therefore, it is plausible
that NDI provides an index for inﬂammatory processes
such as cellular swelling. In rodent studies peripheral
inﬂammation has been associated with both an increase
in astrocytic (speciﬁcally microglial) cell body size and a
reduction in microglial processes (Rivest, 2009). NODDI
is potentially sensitive to both of these processes. How-
ever, it is important to note that a number of complex fac-Table 2. Pearson’s correlation coeﬃcient (R) and statistical signiﬁcance (p) of
post ﬁrst IFN-a injection) with change in fatigue at 5 h (acute), 4 weeks, and 8
Correlation with D fVAS Statistic L striatum
D NDI (4 h) R 0.692
p 0.001
D NDI (4 weeks) R 0.664
p 0.003
D NDI (8 weeks) R 0.651
p 0.003
D ODI (4 h) R 0.068
p 0.789
D ODI (4 weeks) R 0.201
p 0.425
D ODI (8 weeks) R 0.248
p 0.320
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imaging. Not least, subtle changes in the relaxation prop-
erties of discrete microstructural compartments will also
manifest as changes in NDI. Indeed, our prior qMT study
on a partially overlapping cohort revealed a subtle
decrease in T2f in the left striatum (Dowell et al., 2016).
However, we observed no signiﬁcant correlation between
changes in T2f and the changes to NDI (data not shown).
This suggests that the T2 changes in the intracellular com-
ponent are absent or too small to eﬀect a measurable
change in NDI.
Interestingly, our current study revealed that, although
the striatum and insula showed no signiﬁcant diﬀerences
in either NDI or ODI pre- and post-injection, there was a
strong positive correlation between increases in striatal
NDI and the experience of fatigue both acutely and at 4
and 8 weeks later into treatment. These data suggest
that changes in intracellular water (possibly within
microglia) play a role in the emergence of IFN-a-induced
fatigue. They also reinforce the observation that the
striatum is a key brain area targeted by IFN with
implications for impaired motivation. In keeping with our
previous qMT ﬁndings, there was no correlation
between changes in any of the NODDI metrics and
acute or later change in mood measured using the
HAMD questionnaire. This further strengthens the notion
that distinct mechanisms underpin the action of IFN-a
on fatigue and depressive symptoms.
Our previous qMT ﬁndings were striking in that striatal
changes were predominantly lateralized to the left
hemisphere. It is therefore compelling that the same
lateralization pattern was also observed in the present
study, with changes in NDI again correlating with fatigue
most strongly in the left striatum (with only trend-level
signiﬁcance on the right) (Fig. 2). This left-sided
laterality appears to be a recurring theme in studies of
inﬂammatory challenge across a broad range of imaging
modalities. For example, it has been observed in an
FDG PET study linking changes in glucose uptake in
the left ventral striatum to fatigue (Capuron et al., 2007)
and a MR spectroscopy study that revealed that left but
not right IFN-a-induced changes in striatal glutamate/cre-
atine ratio correlated with associated changes in
motivation.correlations between acute change in NODDI metrics (baseline to 4 h
weeks post-onset of IFN-a treatment (p < 0.05 shown in bold)
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Fig. 2. Voxel-wise correlation analysis of acute change in NDI (baseline to 4 h) with acute change
in fatigue (baseline to 4 h). (A) 80-mm ﬁeld of view focused on the striatal regions of interest. (B)
Location of changes in qMT previously reported in Dowell et al., 2016. Data illustrated at an
uncorrected threshold of p< 0.001.
Table 3. Brain areas with positive correlation of acute change in NDI
with acute fatigue. *Indicates a priori regions of interest. FWE-corr =













Left striatum* 1.4 4.33 22,0,16 0.084
Right insula* 1.8 4.19 36,12,8 0.037
Precentral gyrus 2.0 4.48 14,30,50 0.023
Occipital cortex 19.4 4.54 48,68,24 <0.001
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scanned twice) could be considered a potential limitation
of this study. However, our use of a within-subject study
design serves to partially mitigate this by aﬀording
improved power and sensitivity over cross-sectional or
between-group studies. Recently, the NODDI model has
also attracted some criticism recently regarding the use
of a number of assumptions that, if violated, can result
in either a positive or negative bias in the NODDI
parameters (Jelescu et al., 2016; Lampinen et al.,
2017). While the model has some limitations, it is impor-
tant to acknowledge that the same is true for all models
that attempt to use the microstructure from diﬀusion-
weighted imaging data. Furthermore, NODDI provides
improved characterization of tissue microstructure com-
pared to the more simplistic models such as diﬀusion ten-
sor imaging.
To conclude, we used NODDI to probe subtle
changes to tissue microstructure associated with IFN-a.
This revealed a strong correlation between changes in
NDI and the level of fatigue experienced both acutely
and longer into the treatment regimen. While this
represents a complementary quantitative MR imaging
approach to qMT, it is important to note that these
techniques are completely independent and use
diﬀerent imaging data and diﬀerent analysis pipelines.
As a consequence, it is compelling that both qMT and
NODDI implicate the striatum so strongly in the
development of fatigue in patients treated with IFN-a.Please cite this article in press as: Dowell NG et al. Interferon-alpha-Induced Changes in NODDI Predispose to the Development of Fatigue. NeuroACKNOWLEDGMENTS
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